Loading viewer...
investor_presentation
Format: PDF investor_presentation
Cover Title Goes here Uber T echnologies, Inc. Q4 2019 EarningsSupplemental Data Feb 6, 2020
Cover Title Goes here
Uber T echnologies, Inc. Q4 2019 EarningsSupplemental Data
Feb 6, 2020Q4 2019 Earnings
2T o supplement our financial information, which is prepared and presented in accordance with generally accepted accounting principles in the United States of America, or GAAP , we use the following non-GAAP financial measures: Adjusted Net Revenue, Rides Adjusted Net Revenue, Eats Adjusted Net Revenue, Adjusted EBITDA, Adjusted EBITDA as a percentage of Adjusted Net Revenue, Rides Adjusted EBITDA as a percentage of Rides Adjusted Net Revenue, Eats Adjusted EBITDA as a percentage of Eats Adjusted Net Revenue, Eats Adjusted Net Revenue excluding Eats India, Eats Adjusted EBITDA excluding Eats India, Adjusted Costs and expenses, as well as Adjusted Net Revenue, Rides Adjusted Net Revenue and Eats Adjusted Net Revenue growth on a constant currency basis and Y oY % growth on a constant currency basis and ex-driver appreciation award. We believe that these non-GAAP financial measures provide meaningful supplemental information regarding our performance by excluding certain items that may not be indicative of our recurring core business operating results. We believe that both management and investors benefit from referring to these non-GAAP financial measures in assessing our performance and when planning, forecasting, and analyzing future periods. These non-GAAP financial measures also facilitate management’s internal comparisons to our historical performance. We believe these non-GAAP financial measures are useful to investors both because (1) they allow for greater transparency with respect to key metrics used by management in its financial and operational decision-making and (2) they are used by our institutional investors and the analyst community to help them analyze the health of our business. There are a number of limitations related to the use of non-GAAP financial measures. In light of these limitations we provide specific information regarding the GAAP amounts excluded from these non-GAAP financial measures and evaluating these non-GAAP financial measures together with their relevant financial measures in accordance with GAAP . For more information on these non-GAAP financial measures, please see the section titled “Non-GAAP Reconciliations” included at the end of this deck. In regards to forward looking guidance provided on our Q4 2019 earnings call, we are not able to reconcile the forward-looking non-GAAP Adjusted EBITDA measure to the closest corresponding GAAP measure without unreasonable efforts because we are unable to predict the ultimate outcome of certain significant items. These items include, but are not limited to, significant legal settlements, tax and regulatory reserve changes, restructuring costs and acquisition and financing related impacts. Non-GAAP Financial Measures DisclosureQ4 2019 Earnings
3Forward Looking Statements
Preview truncated — download the full document for the complete content.
earnings
31 Pages
investor_presentation
40 Pages
Karyopharm Therapeutics Inc.
investor_presentation
Baytex